Enterprise AI & Automation
Enterprise AI & Automation for Operationally‑Intensive and Regulated Businesses.
Most companies don’t fail at AI. They fail at turning AI into accountable business outcomes.
SreyCapital partners with CEOs, CFOs, and COOs to design and run AI portfolios that move P&L, withstand board and regulatory scrutiny, and actually change how the business operates.
Contact Us
info@sreycapital.com
(856) 242-4222
What We Do
AI Strategy & Portfolio Design
Define where AI creates real value in your business, how to sequence initiatives, and how to fund, staff, and govern them.
AI Operating Model & Governance
Design the structures, processes, and guardrails that keep AI safe, compliant, and aligned to business and risk appetite.
GenAI & LLM Platform Strategy
Decide what to build, what to buy, and how to integrate GenAI responsibly into core systems and workflows.
Intelligent Automation at Scale
Use AI and automation to eliminate manual work, reduce errors, and free teams for higher‑value activities.
AI Talent & CoE Design
Shape the AI Center of Excellence, roles, and skills needed to sustain AI over time.
How We Work
Embedded, accountable, and pragmatic
We work as a fractional Chief AI Officer and enterprise AI partner, embedded with your leadership team.
Board‑aware. We translate AI strategy, risk, and value into language boards and audit/risk committees can act on.
Operator first. We have built and run AI and automation in messy, real‑world environments—field services, water utilities, insurance, digital payments and more.
Regulation‑ready. We partner with Risk, Compliance, and Legal to ensure AI meets regulatory expectations, not just technical best practices.
Change‑focused. We design for adoption—roles, incentives, workflows, and training—not just for the model.
Engagements can be project‑based or ongoing fractional CAIO support.
Ready to turn AI into accountable outcomes?
Share a bit about your business and priorities, and we’ll respond with a practical perspective on where AI can have impact in the next 6–18 months.